Chemed (NYSE: CHE)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-26 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 4.470 | 4.790 | 0.3200 | ||||
REV | 538.570M | 530.549M | -8.021M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Chemed (NYSE: CHE) through any online brokerage.
Other companies in Chemed’s space includes: CVS Health (NYSE:CVS), Signify Health (NYSE:SGFY), LHC Gr (NASDAQ:LHCG), Agiliti (NYSE:AGTI) and Privia Health Group (NASDAQ:PRVA).
The latest price target for Chemed (NYSE: CHE) was reported by RBC Capital on Thursday, April 28, 2022. The analyst firm set a price target for 592.00 expecting CHE to rise to within 12 months (a possible 24.73% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Chemed (NYSE: CHE) is $474.63 last updated Today at June 28, 2022, 3:19 PM UTC.
A quarterly cash dividend of $0.36 per share of Class A Common Stock. The quarterly cash dividend was payable on June 15, 2022 to stockholders of record on May 25, 2022.
Chemed’s Q2 earnings are confirmed for Tuesday, July 26, 2022.
There is no upcoming split for Chemed.
Chemed is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.